Pfizer, Nvidia Support AI Drug Discovery company With a $80 million funding round, AI company CytoReason plans to bring its disease-modeling platform to the United States in order to expedite the process of finding new drugs. A $80 million investment has been obtained by the Israeli startup CytoReason to expedite the development of…
New microservices from NVIDIA strengthen sovereign AI. Nations are increasingly adopting sovereign AI policies, which involve building AI using their own infrastructure, data, and knowledge, to guarantee that systems match local values and rules. NVIDIA is supporting this initiative by introducing four new NVIDIA NIMs. These microservices enable locally customized community models by streamlining the…
With its sales of AI hardware, Nvidia ought to be printing money right now. Rather, Its Stock Is Declining
Nvidia Stock Drops as Earnings Indicate AI
Isn’t Increasing Sales as Expected
